CTGCT
  • en
    • si
  • About us
    • Partners
    • Publications
  • Job Openings
  • Products and Services
  • Learning Box
  • POSTS
    • Events
    • Articles
    • News
  • Get in touch

Gregor Cuzak

  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Marketaccess
  • CTGCT
  • NIC
  • Gregor Cuzak
20 May 2025 Event Date: 1 May 2025 do: 31 May 2025 •

Posters at Krakovski nasip – Ljubljanica embankment

In May 2025, our Centre for the Technologies of Gene and Cell Therapy CTGCT) is participating in a poster exhibition on Krakovski nasip, as part of the Chemical Institute’s public presentation.

  • Events
  • Researchers
  • GLP
  • GMP
  • Drug Discovery
  • Laboratory
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
3 March 2025 Event Date: 10 February 2025 −

Workshop Report: Introduction to 4D-Nucleofector Technology

A hands-on workshop on 4D-Nucleofector technology provided insights into gene transfer using Lonza’s Core- and X units. Participants learned about nucleofection, optimized protocols, and best practices for efficient gene delivery in cell-based research.

20250210 123113
  • Articles
  • Pacients
  • CTGCT
  • Gregor Cuzak
18 February 2025

Hugs for rare

The 28th of February is approaching which is the Day of Rare diseases. Hugs are being collected in 7 countries to raise awareness of the importance of everyone working together to defeat rare diseases.

Hugs1
  • ATMPs
  • Business Model
  • Economics
  • CTGCT
  • UCL
  • Gregor Cuzak
12 February 2025

Introduction to IP and commercialisation – by UCL

The workshop took place on February 3d and was attended by the CTGCT advanced partners only. It provided an in-depth discussion on Intellectual Property (IP) and the process of commercializing research findings. The session ...

  • Events
  • Researchers
  • Cell therapy
  • Laboratory
  • CTGCT
  • Gregor Cuzak
11 February 2025 Event Date: 15 January 2025 do: 16 January 2025 •

Workshop: Introduction to the production of viruses using bioreactor

On 15th January a Sartorius employee gave us a lecture on Ambr250 bioreactor and its accompanying software, which we have on trial. Together we set up the protocol and parameters for our bioprocess (gas ...

20250115 100039
  • Events
  • Researchers
  • Cell therapy
  • Laboratory
  • CTGCT
  • Gregor Cuzak
11 February 2025 Event Date: 13 January 2025 do: 14 January 2025 •

Workshop: Introduction to the TFF system

An employee from Sartorius came on the morning of 13th January to show us the handling of the TFF system Sartoflow Smart, which we have on trial

  • Media Releases
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Economics
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
22 January 2025

Slovenia Joins ERDERA to Advance Rare Disease Research and Collaboration

CTGCT welcomes Slovenia's entry into the European Research Partnership for Rare Diseases ERDERA

Erdera
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • GLP
  • GMP
  • Clinic study
  • Drug Discovery
  • Economics
  • Investment
  • Laboratory
  • Marketaccess
  • Pre Clinical
  • Regulation
  • Charite Berlin
  • CTGCT
  • NIC
  • UCL
  • UMCUtrecht
  • Gregor Cuzak
2 October 2024 Event Date: 18 October 2024 −

Program Announcement CTGCT Conference, 18th Oct 2024

Translational Medicine Ecosystem Ljubljana, Slovenia, Friday 18th October 2024, Location: Kemijski inštitut online transmission of event: webex teleconferencing link   8:30 Registration 9:00 Welcome Addresses Gregor Anderluh, National Institute of Chemistry Mojca Benčina, CTGCT ...

  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Drug Discovery
  • Economics
  • Investment
  • Marketaccess
  • Regulation
  • Research
  • CTGCT
  • Gregor Cuzak
12 September 2024 Event Date: 6 September 2024 • 09:00 do: 6 September 2024 •

European Commission Hosts Sixth Regional HTA Event in Budapest

The European Commission recently held its sixth regional event in Budapest, focusing on the upcoming Health Technology Assessment (HTA) regulation. Set to launch in January 2025, this new framework aims to streamline the evaluation ...

Hta 20230511 Banner 0
  • Events
  • Researchers
  • CTGCT
  • NIC
  • Gregor Cuzak
12 August 2024

ADVANCE Workshop in June 2024

A diverse organising committee of various faculties from the University of Ljubljana organised a 5-day workshop called ADVANCE dedicated to translational medicine for advanced therapy medicinal products (ATMPs). Our Darja Marolt Presen participated. The ...

Advance 2024
  • Events
  • Clinicians
  • Researchers
  • Gen Therapy
  • Drug Discovery
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
17 July 2024

CTGCT about on/off switching of CAR-Ts at the EBMT 2024

Assoc. Prof Dr Mojca Benčina, head of the newly founded Slovenian Centre for the Technologies of Gene and Cell Therapy (CTGCT), gave a speech at the recent 50th Annual Meeting of the European Society ...

Featured Up Regulation
  • Clinicians
  • Researchers
  • Cell therapy
  • Gen Therapy
  • GMP
  • Business Model
  • Clinic study
  • Drug Discovery
  • Economics
  • Investment
  • Logistics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • UCL
  • Gregor Cuzak
17 July 2024

UCL ATMP Pipeline

Our partner University College London (UCL) have produced a great short brochure (link) showing the strength and depth  of their pipeline of ATMPs. They use a managed portfolio approach in which they support ~100 ...

Pipeline By Number Of Projects

Posts pagination

1 2

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ministry Logo

 

Project: 101059842 – CTGCT – HORIZON-WIDERA-2022

Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them


CTGCT © 2025
Website production: Kreativna tovarna